BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2506685)

  • 1. [Rhesus immunization in a rhesus-positive pregnant woman: fetal erythroblastosis caused by the rhesus antibody anti-C].
    Konstantin-Hansen KF; Larsen HL; Hejl M
    Ugeskr Laeger; 1989 Jun; 151(24):1553. PubMed ID: 2506685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 4. [Decreasing Rhesus serum antibody titer in pregnancy with Rhesus constellation].
    Kölbl H; Riss P
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):285-6. PubMed ID: 3110000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhesus antagonism, sometimes different from usual].
    Rodrigues Pereira R; Van Wilgenburg MG
    Tijdschr Kindergeneeskd; 1989 Aug; 57(4):136-8. PubMed ID: 2508264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systematic detection of anti-erythrocyte alloimmunization during pregnancy. Experience at the Lyon Regional Blood Transfusion Center].
    Moncharmont P; Juron-Dupraz F; Vignal M; Rigal D
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):321-4. PubMed ID: 2500475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perinatal hemolytic disease caused by anti-c. A clinical case].
    Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
    Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden.
    Gottvall T; Filbey D
    Acta Obstet Gynecol Scand; 2008; 87(8):843-8. PubMed ID: 18704776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
    Berlin G; Selbing A; Gottvall T
    Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemolytic disease of two newborns in a Rhesus anti-e alloimmunized woman. Review of literature.
    Moncharmont P; Juron-Dupraz F; Rigal D; Vignal M; Meyer F
    Haematologia (Budap); 1990; 23(2):97-100. PubMed ID: 2125572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is rhesus prophylaxis indicated also with positive antibodies?].
    Behrens O
    Z Geburtshilfe Neonatol; 1996; 200(6):246. PubMed ID: 9081755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.